News

BeamOne is planning to establish its new electron beam medical device sterilisation service center in the Pittsburgh, PA. Reportedly the inauguration is expected to begin on the new

Beardsworth has selected OmniComm Systems’ (OmniComm) TrialMaster EDC solution for conducting a Phase II vaccine study. The three-year, ten-site study is planning to enroll 340 subjects. OmniComm and

Pharmasset has announced that the enrollment of Cohort 2, led by Roche, will continue for the remaining 300 genotype 1 and 4 patients in the ongoing phase 2b

Astellas will install PAS-X at its production site in Meppel. PAS-X is an EBR (Electronic Batch Recording). PAS-X will be installed at the company’s pharmaceutical solids production and

The Drug Controller General of India (DCGI) will soon implement the e-governance model adopted by Food and Drug Control Administration (FDCA), Gujarat, India, in the Central Drug Standard

Health Canada has issued a warning relating to possible manufacturing problems with Caninsulin. Caninsulin is a drug aimed at treatment of diabetes in dogs and cats. Health Canada

i3 has entered into an agreement with Acurian, to provide study sponsors with a solution to recruit investigators for clinical trials. Acurian’s patient database will be complemented by

Malvern Instruments has launched the Kinexus rheometry platform, which is used to develop and apply design rules and also allows a formulation or product microstructure to be made.

Khaleej Times reported that an investment of E100m is being made to establish a biologics manufacturing plant in Abu Dhabi. The plant will manufacture drugs for the Middle